AdvisorShares Investments LLC historic quarter change: USA Other Stocks, Added
In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, AdvisorShares Investments LLC opened 28 positions, added to 52, reduced 17 and sold out of 43.
- Q2 2026: Stock CHARLOTTES WEB HOLDINGS I; Country of operation —; Class Common Stock; Shares before 2,296,805.
- Q1 2026: Stock CHARLOTTES WEB HOLDINGS I; Country of operation —; Class Common Stock; Shares before 2,284,556.
- Q1 2026: Stock CANNARA BIOTECH INC; Country of operation —; Class Common Stock; Shares before 215,750.
- Q1 2026: Stock SILO PHARMA INC; Country of operation United States; Class Common Stock; Shares before 599,507.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1425930), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-11); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-04-28); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-10); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-05); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-04); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-13); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-07); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2019-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q2 2026 | CHARLOTTES WEB HOLDINGS I
CUSIP 00BGHY2B1 | | Common Stock | 2,296,805 | 3,026,805 | +730,000 | $1,645,806 | $938,710 | -$707,096 | 2026-08-11 |
|---|
| Q1 2026 | CHARLOTTES WEB HOLDINGS I
CUSIP 00BGHY2B1 | | Common Stock | 2,284,556 | 2,296,805 | +12,249 | $824,990 | $1,645,806 | +$820,816 | 2026-04-28 |
|---|
| Q1 2026 | CANNARA BIOTECH INC
CUSIP 00BMZMHL4 | | Common Stock | 215,750 | 247,894 | +32,144 | $273,868 | $314,408 | +$40,540 | 2026-04-28 |
|---|
| Q1 2026 | SILO PHARMA INC
CUSIP 82711P201 | United States | Common Stock | 599,507 | 663,965 | +64,458 | $203,832 | $238,828 | +$34,996 | 2026-04-28 |
|---|
| Q4 2025 | CHARLOTTES WEB HOLDINGS I
CUSIP 00BGHY2B1 | | Common Stock | 2,039,555 | 2,284,556 | +245,001 | $344,470 | $824,990 | +$480,520 | 2026-02-10 |
|---|
| Q4 2025 | ATAI BECKLEY NV
CUSIP N0731H103 | | Common Stock | 506,311 | 548,603 | +42,292 | $2,678,385 | $2,243,786 | -$434,599 | 2026-02-10 |
|---|
| Q4 2025 | SILO PHARMA INC
CUSIP 82711P201 | United States | Common Stock | 364,878 | 599,507 | +234,629 | $251,766 | $203,832 | -$47,934 | 2026-02-10 |
|---|
| Q4 2025 | INCANNEX HEALTHCARE INC
CUSIP 45333F109 | | Common Stock | 471,278 | 663,727 | +192,449 | $218,814 | $237,614 | +$18,800 | 2026-02-10 |
|---|
| Q3 2025 | ATAI LIFE SCIENCES NV
CUSIP N0731H103 | | Common Stock | 389,762 | 506,311 | +116,549 | $853,579 | $2,678,385 | +$1,824,806 | 2025-11-05 |
|---|
| Q3 2025 | TILRAY BRANDS INC
CUSIP 88688T100 | | Common Stock | 491,535 | 711,535 | +220,000 | $203,692 | $1,230,956 | +$1,027,264 | 2025-11-05 |
|---|
| Q3 2025 | PREMIER INC-CLASS A
CUSIP 74051N102 | United States | Common Stock | 19,706 | 21,632 | +1,926 | $432,153 | $601,370 | +$169,217 | 2025-11-05 |
|---|
| Q3 2025 | INCANNEX HEALTHCARE INC
CUSIP 45333F109 | | Common Stock | 343,954 | 471,278 | +127,324 | $74,191 | $218,814 | +$144,623 | 2025-11-05 |
|---|
| Q3 2025 | SILO PHARMA INC
CUSIP 82711P201 | United States | Common Stock | 184,236 | 364,878 | +180,642 | $116,069 | $251,766 | +$135,697 | 2025-11-05 |
|---|
| Q3 2025 | ENVERIC BIOSCIENCES INC
CUSIP 29405E406 | United States | Common Stock | 103,679 | 203,679 | +100,000 | $125,452 | $130,232 | +$4,780 | 2025-11-05 |
|---|
| Q2 2025 | INCANNEX HEALTHCARE INC
CUSIP 45333F109 | | Common Stock | 295,034 | 343,954 | +48,920 | $199,148 | $74,191 | -$124,957 | 2025-08-04 |
|---|
| Q2 2025 | CANNARA BIOTECH INC
CUSIP 00BMZMHL4 | | Common Stock | 120,000 | 221,700 | +101,700 | $109,719 | $229,093 | +$119,374 | 2025-08-04 |
|---|
| Q2 2025 | TILRAY BRANDS INC
CUSIP 88688T100 | | Common Stock | 487,735 | 491,535 | +3,800 | $319,076 | $203,692 | -$115,384 | 2025-08-04 |
|---|
| Q2 2025 | SILO PHARMA INC
CUSIP 82711P201 | United States | Common Stock | 124,236 | 184,236 | +60,000 | $140,387 | $116,069 | -$24,318 | 2025-08-04 |
|---|
| Q2 2025 | PLAYAGS INC
CUSIP 72814N104 | United States | Common Stock | 27,000 | 28,000 | +1,000 | $326,430 | $349,720 | +$23,290 | 2025-08-04 |
|---|
| Q2 2025 | INTERCURE LTD
CUSIP M549GJ111 | | Common Stock | 108,044 | 108,884 | +840 | $149,101 | $160,059 | +$10,958 | 2025-08-04 |
|---|
| Q2 2025 | ENVERIC BIOSCIENCES INC
CUSIP 29405E406 | United States | Common Stock | 90,324 | 103,679 | +13,355 | $118,324 | $125,452 | +$7,128 | 2025-08-04 |
|---|
| Q2 2025 | CHARLOTTES WEB HOLDINGS I
CUSIP 00BGHY2B1 | | Common Stock | 2,023,875 | 2,039,555 | +15,680 | $183,635 | $186,841 | +$3,206 | 2025-08-04 |
|---|
| Q2 2025 | FLORA GROWTH CORP
CUSIP 339764201 | | Common Stock | 70,420 | 70,960 | +540 | $42,245 | $41,157 | -$1,088 | 2025-08-04 |
|---|
| Q2 2025 | PHARMACIELO LTD
CUSIP 00BH4KPJ8 | | Common Stock | 340,491 | 343,171 | +2,680 | $15,447 | $16,347 | +$900 | 2025-08-04 |
|---|
| Q1 2025 | SAGE THERAPEUTICS INC
CUSIP 78667J108 | United States | Common Stock | 47,800 | 83,642 | +35,842 | $259,554 | $657,426 | +$397,872 | 2025-05-13 |
|---|
| Q1 2025 | INCANNEX HEALTHCARE INC
CUSIP 45333F109 | | Common Stock | 165,495 | 295,034 | +129,539 | $350,849 | $199,148 | -$151,701 | 2025-05-13 |
|---|
| Q1 2025 | ATAI LIFE SCIENCES NV
CUSIP N0731H103 | | Common Stock | 311,490 | 408,762 | +97,272 | $414,282 | $506,865 | +$92,583 | 2025-05-13 |
|---|
| Q4 2024 | ATAI LIFE SCIENCES NV
CUSIP N0731H103 | | Common Stock | 167,831 | 311,490 | +143,659 | $194,684 | $414,282 | +$219,598 | 2025-02-14 |
|---|
| Q4 2024 | CHARLOTTES WEB HOLDINGS I
CUSIP 00BGHY2B1 | | Common Stock | 2,012,115 | 2,023,875 | +11,760 | $290,434 | $175,903 | -$114,531 | 2025-02-14 |
|---|
| Q4 2024 | INCANNEX HEALTHCARE INC
CUSIP 45333F109 | | Common Stock | 126,990 | 165,495 | +38,505 | $252,710 | $350,849 | +$98,139 | 2025-02-14 |
|---|
| Q4 2024 | SAGE THERAPEUTICS INC
CUSIP 78667J108 | United States | Common Stock | 23,330 | 47,800 | +24,470 | $168,443 | $259,554 | +$91,111 | 2025-02-14 |
|---|
| Q4 2024 | INTRA-CELLULAR THERAPIES
CUSIP 46116X101 | United States | Common Stock | 2,805 | 3,263 | +458 | $205,242 | $272,526 | +$67,284 | 2025-02-14 |
|---|
| Q4 2024 | INTERCURE LTD
CUSIP M549GJ111 | | Common Stock | 107,414 | 108,044 | +630 | $215,902 | $172,870 | -$43,032 | 2025-02-14 |
|---|
| Q4 2024 | ENVERIC BIOSCIENCES INC
CUSIP 29405E208 | United States | Common Stock | 367,047 | 599,854 | +232,807 | $173,980 | $214,988 | +$41,008 | 2025-02-14 |
|---|
| Q4 2024 | PHARMACIELO LTD
CUSIP 00BH4KPJ8 | | Common Stock | 338,496 | 340,491 | +1,995 | $45,101 | $18,940 | -$26,161 | 2025-02-14 |
|---|
| Q3 2024 | SKYE BIOSCIENCE INC
CUSIP 83086J200 | United States | Common Stock | 26,000 | 115,000 | +89,000 | $209,560 | $449,650 | +$240,090 | 2024-11-14 |
|---|
| Q3 2024 | ARCH RESOURCES INC
CUSIP 03940R107 | United States | Common Stock | 3,030 | 3,522 | +492 | $511,010 | $486,600 | -$24,410 | 2024-11-14 |
|---|
| Q3 2024 | ENVERIC BIOSCIENCES INC
CUSIP 29405E208 | United States | Common Stock | 317,047 | 367,047 | +50,000 | $189,911 | $173,980 | -$15,931 | 2024-11-14 |
|---|
| Q3 2024 | INCANNEX HEALTHCARE INC
CUSIP 45333F109 | | Common Stock | 80,002 | 126,990 | +46,988 | $237,606 | $252,710 | +$15,104 | 2024-11-14 |
|---|
| Q3 2024 | SAGE THERAPEUTICS INC
CUSIP 78667J108 | United States | Common Stock | 16,030 | 23,330 | +7,300 | $176,811 | $168,443 | -$8,368 | 2024-11-14 |
|---|
| Q2 2024 | CURALEAF HOLDINGS INC
CUSIP 23126M102 | | Common Stock | 9,352,610 | 10,468,126 | +1,115,516 | $51,252,303 | $40,616,329 | -$10,635,974 | 2024-08-07 |
|---|
| Q2 2024 | ATAI LIFE SCIENCES NV
CUSIP N0731H103 | | Common Stock | 182,188 | 200,831 | +18,643 | $358,910 | $271,122 | -$87,788 | 2024-08-07 |
|---|
| Q2 2024 | SAGE THERAPEUTICS INC
CUSIP 78667J108 | United States | Common Stock | 14,112 | 16,030 | +1,918 | $264,459 | $176,811 | -$87,648 | 2024-08-07 |
|---|
| Q2 2024 | INCANNEX HEALTHCARE INC
CUSIP 45333F109 | | Common Stock | 50,915 | 80,002 | +29,087 | $182,785 | $237,606 | +$54,821 | 2024-08-07 |
|---|
| Q2 2024 | ENVERIC BIOSCIENCES INC
CUSIP 29405E208 | United States | Common Stock | 238,833 | 317,047 | +78,214 | $238,833 | $189,911 | -$48,922 | 2024-08-07 |
|---|
| Q1 2024 | TILRAY BRANDS INC
CUSIP 88688T100 | | Common Stock | 574,900 | 674,900 | +100,000 | $1,322,270 | $1,667,003 | +$344,733 | 2024-05-14 |
|---|
| Q1 2024 | VECTOR GROUP LTD
CUSIP 92240M108 | United States | Common Stock | 25,763 | 32,882 | +7,119 | $290,607 | $360,387 | +$69,780 | 2024-05-14 |
|---|
| Q1 2024 | ENVERIC BIOSCIENCES INC
CUSIP 29405E208 | United States | Common Stock | 141,833 | 238,833 | +97,000 | $184,383 | $238,833 | +$54,450 | 2024-05-14 |
|---|
| Q1 2024 | SAGE THERAPEUTICS INC
CUSIP 78667J108 | United States | Common Stock | 13,362 | 14,112 | +750 | $289,555 | $264,459 | -$25,096 | 2024-05-14 |
|---|
| Q1 2024 | SEELOS THERAPEUTICS INC
CUSIP 81577F208 | United States | Common Stock | 181,259 | 462,694 | +281,435 | $251,950 | $273,452 | +$21,502 | 2024-05-14 |
|---|
| Q1 2024 | INTRA-CELLULAR THERAPIES
CUSIP 46116X101 | United States | Common Stock | 4,151 | 4,575 | +424 | $297,295 | $316,590 | +$19,295 | 2024-05-14 |
|---|
| Q1 2024 | INCANNEX HEALTHCARE INC
CUSIP 45333F109 | | Common Stock | 38,757 | 50,915 | +12,158 | $179,832 | $182,785 | +$2,953 | 2024-05-14 |
|---|